Skip to content
Screener

Discontinued — last reported Q2 '26

R&D at other companies

Innospec logo
InnospecIOSP
$13.2M+3.9%
Eastman Chemical logo
Eastman ChemicalEMN
$60M-10.4%
Ingevity logo
IngevityNGVT
$6.7M-4.3%
Materion logo
MaterionMTRN
$6.56M+2.3%
Element Solutions logo
Element SolutionsESI
$19.5M+20.4%
Ashland logo
AshlandASH
$15M+15.4%

Segments

By segment

See full
Petroleum Additives-$30.39M+6.1%

Other financials

Income statement

See full
Revenue$747.1M+7.0%
Gross profit$242.4M+9.7%
Operating income$163.7M+14.3%
Net income$133.8M+20.2%
EPS (diluted)$14.54+22.8%

Balance sheet

See full
Cash & equivalents$93.6M+33.2%
Total debt$939.9M+2.3%
Total equity$1.8B+14.1%
Total assets$3.6B+13.4%

Cash flow

See full
Operating cash flow$162.1M+0.6%
CapEx$27.4M+68.2%
Free cash flow$134.7M-6.9%

Valuation

See full
Market cap$8.11B+19.5%
Enterprise value$8.95B+17.3%
P/E18.7×+4.6×
P/S+0.5×

Profitability

See full
Gross margin31.5%-1.2pp
Operating margin20%-1.8pp
Net margin15.8%-1.5pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity25.1%-8.6pp
Debt / equity0.5×-0.1×
Current ratio2.3×-0.4×

Where this comes from

Reported directly by NewMarket in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: NewMarket’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 8:42 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001282637-26-000016
(in thousands, except per-share amounts)Second Quarter Ended June 30, 2026Second Quarter Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Cost of goods sold504,665477,555953,503942,478
Gross profit242,429220,954463,308456,977
Selling, general, and administrative expenses48,37645,42894,39088,406
Research, development, and testing expenses30,38832,37462,02465,550
Operating profit163,665143,152306,894303,021
Interest and financing expenses, net8,81810,73517,58921,435
Other income (expense), net15,49115,27132,68730,215
Income before income tax expense170,338147,688321,992311,801

Item 1. Financial Statements (unaudited)

FAQ

What is NewMarket's R&D?
NewMarket (NEU) reported R&D of $30.39M in Q2 2026.
How has NewMarket's R&D changed year-over-year?
NewMarket's R&D decreased by 6.1% year-over-year, from $32.37M to $30.39M.
What is the long-term trend for NewMarket's R&D?
Over 4 years (2021 to 2025), NewMarket's R&D has grown at a -2.1% compound annual growth rate (CAGR), from $143.95M to $132.09M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about NewMarket's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude